Navigation Links
Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
Date:11/5/2012

DUBLIN, Nov. 5, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today its support of The Partnership at Drugfree.org's recently launched national action campaign, The Medicine Abuse Project. The initiative is intended as a multi-year public awareness and education campaign designed to curb abuse of prescription medicine among teens. 

A new study conducted by The Partnership at Drugfree.org found that medicine abuse is a growing problem among teens in the U.S., with one in six teens taking medicine to get high or change his or her mood.  According to the Centers for Disease Control and Prevention, drug overdoses now surpass car crashes as the leading cause of accidental death in the U.S., and opioid pain relievers are responsible for more overdose deaths than cocaine and heroin combined.

"The need for a serious national medicine abuse prevention effort and our strong commitment to patient safety are the reasons we became an active supporter in The Medicine Abuse Project," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  "As a specialty biopharmaceutical company that makes products for highly complicated and specialized disease states, we understand the importance of incorporating systems to ensure the safe and appropriate use of our products.  We believe that we can make a meaningful difference in this effort to combat medicine abuse."

"The majority of teens who abuse medicines get them from family and friends," said Steve Pasierb, president and chief executive officer of The Partnership for Drugfree.org. "We need to change that. With the support of partners like Jazz Pharmaceuticals, physicians, parents and teens themselves will be more aware of the dangers of medicine abuse."

This important collaborative effort to raise awareness and combat medicine abuse reflects Jazz Pharmaceuticals' commitment to patient safety.  As part of The Medicine Abuse Project, the company encourages individuals to sign the Pledge at MedicineAbuseProject.org, and many of its employees have already participated in this effort.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate), Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, Luvox CR® (fluvoxamine maleate), FazaClo® (clozapine, USP) HD and FazaClo LD. Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its international division, EUSA Pharma.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2017)... Pa. , June 1, 2017 Nutriceutical ... and Veterinarian Recommended Solutions (VRS), and KD Pharma Group ... in Nutriceutical Holdings by KD Pharma Group. KD Pharma ... with the option to acquire the entire company. ... in KD. They are committed to growing the NH ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
(Date:5/23/2017)... 2017  Leaf Healthcare, recognized for developing one ... pressure ulcer prevention, will unveil its comprehensive mobility ... Care Nurses, National Teaching Institute and Critical Care ... Leaf Patient Monitoring System is the first mobility ... The system seamlessly tracks patient movement throughout the ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/25/2017)... ... 2017 , ... FCPX LUT Vintage Volume 2 for Final Cut Pro X ... Volume 2 contains 60 different color-grade presets, giving editors multiple options for adding different ... single out subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for ...
(Date:6/25/2017)... CA (PRWEB) , ... June 25, 2017 , ... With a heatwave currently bearing down ... or hanging out at the pool. Being swimsuit ready is easy with laser hair removal. ... and repeat again can be a burdensome routine when all you want to do is ...
(Date:6/24/2017)... (PRWEB) , ... June 24, 2017 , ... The weather ... spend time outdoors. Home and business owners should be aware that the summer months ... lake. In fact, mechanical locks and keys can be negatively affected from direct exposure ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Reconciliation Act (BCRA), their proposed healthcare bill to repeal and replace the Affordable ... the Senate bill would make significant cuts to Medicaid, a public health insurance ...
Breaking Medicine News(10 mins):